Acquired cytochrome C oxidase impairment in apheresis platelets during storage: A possible mechanism for depletion of metabolic adenosine triphosphate

Transfusion

Volumn 52, Issue 5, 2012, Pages 1024-1030

  Diab, Yaser A ^a,b,c,d,e   Thomas, Adia ^a,b,c,d,e   Luban, Naomi L C ^a,b,c,d,e   Wong, Edward C C ^a,b,c,d,e   Wagner, Stephen J ^a,b,c,d,e   Levy, Richard J ^a,b,c,d,e  

^a Center for Cancer and Blood Disorders   (United States)

^b Center for Genetic Medicine Research   (United States)

^c Division of Laboratory Medicine   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OXIDATIVE PHOSPHORYLATION; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE METABOLISM; THROMBOCYTE PRESERVATION; THROMBOCYTOPHERESIS;

ADENOSINE TRIPHOSPHATE; BLOOD PLATELETS; BLOOD PRESERVATION; ELECTRON TRANSPORT COMPLEX IV; HUMANS; PLATELETPHERESIS;

EID: 84861097193     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03446.x     Document Type: Article

References (37)

1. Akkerman JW,. Regulation of carbohydrate metabolism in platelets. A review. Thromb Haemost 1978; 39: 712-24.
2. Murphy S,. Metabolic patterns of platelets-impact on storage for transfusion. Vox Sang 1994; 67 Suppl 3: 271-3.
3. Muravchick S, Levy RJ,. Clinical implications of mitochondrial dysfunction. Anesthesiology 2006; 105: 819-37.
4. Holmsen H,. Nucleotide metabolism of platelets. Annu Rev Physiol 1985; 47: 677-90.
5. Rao AK, Niewiarowski S, Murphy S,. Acquired granular pool defect in stored platelets. Blood 1981; 57: 203-8.
6. Holme S, Heaton WA, Courtright M,. Platelet storage lesion in second-generation containers: correlation with platelet ATP levels. Vox Sang 1987; 53: 214-20.
7. de Korte D, Gouwerok CW, Fijnheer R, Pietersz RN, Roos D,. Depletion of dense granule nucleotides during storage of human platelets. Thromb Haemost 1990; 63: 275-8.
8. Edenbrandt CM, Murphy S,. Adenine and guanine nucleotide metabolism during platelet storage at 22 degrees C. Blood 1990; 76: 1884-92.
9. Kilkson H, Holme S, Murphy S,. Platelet metabolism during storage of platelet concentrates at 22 degrees C. Blood 1984; 64: 406-14.
10. American Association of Blood Banks. Standards for blood banks and transfusion services. 26th ed. Bethesda (MD): American Association of Blood Banks; 2009.
11. Moroff G, Chang CH,. Aggregation response of human platelets stored at 22 C as platelet-rich plasma. Transfusion 1979; 19: 704-18.
12. Summerfield GP, Keenan JP, Brodie NJ, Bellingham AJ,. Bioluminescent assay of adenine nucleotides: rapid analysis of ATP and ADP in red cells and platelets using the LKB luminometer. Clin Lab Haematol 1981; 3: 257-71.
13. Henn V, Steinbach S, Buchner K, Presek P, Kroczek RA,. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001; 98: 1047-54.
14. Lundin A,. Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites. Methods Enzymol 2000; 305: 346-70.
15. Holmsen H, Storm E, Day HJ,. Determination of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma. Anal Biochem 1972; 46: 489-501.
16. Levy RJ, Vijayasarathy C, Raj NR, Avadhani NG, Deutschman CS,. Competitive and noncompetitive inhibition of myocardial cytochrome C oxidase in sepsis. Shock 2004; 21: 110-4.
17. Vijayasarathy C, Biunno I, Lenka N, Yang M, Basu A, Hall IP, Avadhani NG,. Variations in the subunit content and catalytic activity of the cytochrome C oxidase complex from different tissues and different cardiac compartments. Biochim Biophys Acta 1998; 1371: 71-82.
18. Smith L,. Spectrophotometric assay of cytochrome C oxidase. Methods Biochem Anal 1955; 2: 427-34.
19. Weiss YG, Bouwman A, Gehan B, Schears G, Raj N, Deutschman CS,. Cecal ligation and double puncture impairs heat shock protein 70 (HSP-70) expression in the lungs of rats. Shock 2000; 13: 19-23.
20. Kotelba-Witkowska B, Holmsen H, Murer EH,. Storage of human platelets: effects on metabolically active ATP and on the release reaction. Br J Haematol 1972; 22: 429-35.
21. Devine DV, Serrano K,. The platelet storage lesion. Clin Lab Med 2010; 30: 475-87.
22. Mancuso M, Filosto M, Bosetti F, Ceravolo R, Rocchi A, Tognoni G, Manca ML, Solaini G, Siciliano G, Murri L,. Decreased platelet cytochrome C oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease. Exp Neurol 2003; 182: 421-6.
23. Hanagasi HA, Ayribas D, Baysal K, Emre M,. Mitochondrial complex I, II/III, and IV activities in familial and sporadic Parkinson's disease. Int J Neurosci 2005; 115: 479-93.
24. Owens M, Holme S, Heaton A, Sawyer S, Cardinali S,. Post-transfusion recovery of function of 5-day stored platelet concentrates. Br J Haematol 1992; 80: 539-44.
25. Rinder HM, Snyder EL, Tracey JB, Dincecco D, Wang C, Baril L, Rinder CS, Smith BR,. Reversibility of severe metabolic stress in stored platelets after in vitro plasma rescue or in vivo transfusion: restoration of secretory function and maintenance of platelet survival. Transfusion 2003; 43: 1230-7.
26. Bergmeier W, Burger PC, Piffath CL, Hoffmeister KM, Hartwig JH, Nieswandt B, Wagner DD,. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood 2003; 102: 4229-35.
27. Hayashi T, Tanaka S, Hori Y, Hirayama F, Sato EF, Inoue M,. Role of mitochondria in the maintenance of platelet function during in vitro storage. Transfus Med 2011; 21: 166-74.
28. Soslau G,. Cytochrome levels and activity in stored human platelets. Arch Biochem Biophys 1982; 215: 532-8.
29. Valla J, Schneider L, Niedzielko T, Coon KD, Caselli R, Sabbagh MN, Ahern GL, Baxter L, Alexander G, Walker DG, Reiman EM,. Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment. Mitochondrion 2006; 6: 323-30.
30. Kuznetsova SS, Azarkina NV, Vygodina TV, Siletsky SA, Konstantinov AA,. Zinc ions as cytochrome C oxidase inhibitors: two sites of action. Biochemistry (Mosc) 2005; 70: 128-36.
31. Levy RJ, Deutschman CS,. Cytochrome C oxidase dysfunction in sepsis. Crit Care Med 2007; 35 Suppl: S468-75.
32. Vaz AR, Delgado-Esteban M, Brito MA, Bolanos JP, Brites D, Almeida A,. Bilirubin selectively inhibits cytochrome C oxidase activity and induces apoptosis in immature cortical neurons: assessment of the protective effects of glycoursodeoxycholic acid. J Neurochem 2010; 112: 56-65.
33. Yoshikawa S, Orii Y,. The inhibition mechanism of the cytochrome oxidase reaction. II. Classification of inhibitors based on their modes of action. J Biochem 1972; 71: 859-72.
34. Brunori M, Forte E, Arese M, Mastronicola D, Giuffre A, Sarti P,. Nitric oxide and the respiratory enzyme. Biochim Biophys Acta 2006; 1757: 1144-54.
35. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH,. Reversible inhibition of cytochrome C oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994; 345: 50-4.
36. Cooper CE, Brown GC,. The inhibition of mitochondrial cytochrome oxidase by the gases carbon monoxide, nitric oxide, hydrogen cyanide and hydrogen sulfide: chemical mechanism and physiological significance. J Bioenerg Biomembr 2008; 40: 533-9.
37. Turrens JF,. Mitochondrial formation of reactive oxygen species. J Physiol 2003; 552 (Pt 2): 335-44.